Evidence map›Paper›PMID 22768940›Full record

ArticleBiophysical journal2012

Modulation of the pHLIP transmembrane helix insertion pathway.

Alexander G Karabadzhak, Dhammika Weerakkody, Dayanjali Wijesinghe, Mak S Thakur, Donald M Engelman, Oleg A Andreev, Vladislav S Markin, Yana K Reshetnyak

Abstract read
In one paragraph

Article in Biophysical journal, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Arginine Residues Modulate the Membrane Interactions of pHLIP Peptides.Journal of chemical information and modeling · 2023
    Article
  6. CaProtein science : a publication of the Protein Society · 2022
    Article
  7. Pharmacokinetic modeling reveals parameters that govern tumor targeting and delivery by a pH-Low Insertion Peptide (pHLIP).Proceedings of the National Academy of Sciences of the United States of America · 2021
    Article
  8. Article
  9. Kinetics of pHLIP peptide insertion into and exit from a membrane.Proceedings of the National Academy of Sciences of the United States of America · 2020
    Article
  10. Article
  11. Review
  12. Activity and characterization of a pH-sensitive antimicrobial peptide.Biochimica et biophysica acta. Biomembranes · 2019
    Article
  13. Article
  14. Cancer targeting peptides.Cellular and molecular life sciences : CMLS · 2019
    Review
  15. Article
  16. Article
  17. pH-dependent thermodynamic intermediates of pHLIP membrane insertion determined by solid-state NMR spectroscopy.Proceedings of the National Academy of Sciences of the United States of America · 2018
    Article
  18. Review
  19. Membrane-Induced p KJournal of chemical theory and computation · 2018
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Alexander G KarabadzhakPhysics Department, University of Rhode Island, Kingston, Rhode Island, USA.
Dhammika Weerakkody
Dayanjali Wijesinghe
Mak S Thakur
Donald M Engelman
Oleg A Andreev
Vladislav S Markin
Yana K Reshetnyak

Funding

TM INTERACTIONS IN MEMBRANE PROTEIN FOLDING AND FUNCTIONR01GM073857 · NIGMS · YALE UNIVERSITY · PI ANDREEV, OLEG A, ENGELMAN, DONALD M. · 2006 to 2023
$8.4M
pHLIP Nanotechnology Platform for Cancer Imaging and TherapyR01CA133890 · NCI · UNIVERSITY OF RHODE ISLAND · PI ANDREEV, OLEG A, ENGELMAN, DONALD M. · 2008 to 2012
$3.8M
PET Imaging of Cancer with pH (Low) Insertion Peptide (pHLIP)R01CA138468 · NCI · SLOAN-KETTERING INST CAN RESEARCH · PI LEWIS, JASON S. · 2010 to 2013
$2.0M
NCI NIH HHS CA133890NCI NIH HHS CA138468NCI NIH HHS R01 CA133890NCI NIH HHS R01 CA138468NIGMS NIH HHS GM073857NIGMS NIH HHS R01 GM073857
6 · The paper itself

Abstract

The membrane-associated folding/unfolding of pH (low) insertion peptide (pHLIP) provides an opportunity to study how sequence variations influence the kinetics and pathway of peptide insertion into bilayers. Here, we present the results of steady-state and kinetics investigations of several pHLIP variants with different numbers of charged residues, with attached polar cargoes at the peptide's membrane-inserting end, and with three single-Trp variants placed at the beginning, middle, and end of the transmembrane helix. Each pHLIP variant exhibits a pH-dependent interaction with a lipid bilayer. Although the number of protonatable residues at the inserting end does not affect the ultimate formation of helical structure across a membrane, it correlates with the time for peptide insertion, the number of intermediate states on the folding pathway, and the rates of unfolding and exit. The presence of polar cargoes at the peptide's inserting end leads to the appearance of intermediate states on the insertion pathway. Cargo polarity correlates with a decrease of the insertion rate. We conclude that the existence of intermediate states on the folding and unfolding pathways is not mandatory and, in the simple case of a polypeptide with a noncharged and nonpolar inserting end, the folding and unfolding appears as an all-or-none transition. We propose a model for membrane-associated insertion/folding and exit/unfolding and discuss the importance of these observations for the design of new delivery agents for direct translocation of polar therapeutic and diagnostic cargo molecules across cellular membranes.

Indexed as

Amino Acid SequenceCell MembraneHydrogen-Ion ConcentrationKineticsLipid BilayersLiposomesMembrane ProteinsModels, MolecularMolecular Sequence DataPhosphatidylcholinesProtein Structure, SecondaryProtein UnfoldingTemperatureThermodynamics1-palmitoyl-2-oleoylphosphatidylcholineLipid BilayersLiposomesMembrane ProteinspHLIP proteinPhosphatidylcholines

Identifiers

PMID22768940
PMCPMC3328699

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.